A novel automatic injection device developed to increase safety, speed, and ease of use in emergent medical situations.
Patents submitted in key jurisdictions
Prototype under development
A medical device designed to improve hypodermic medication delivery systems with a safer and more robust needle. NeedSafe is the safest needle protective and delivery device to be ever developed.
Patent issued/pending in various jurisdictions
Prototype under development
A connected web and mobile application used for remote patient monitoring to improve patient outcomes and expand upon current clinical capabilities.
Grant submission completed
Seeking alpha development contract
David Kim, MD, MSc, DAvMed
David is a recipient of the BC Community Achievement Award for his work in philanthropy, process optimization, and giving back to his community. He joins Difinity with significant experience in leading and executing within the charitable sector as the founder and director of various non-profit organizations. David is currently a resident physician specializing in emergency medicine at the Vancouver General Hospital with sub-specialty interest in Aerospace Medicine and holds a MSc in Aerospace Medicine from King's College London.
Livleen Veslemes, CMA, CPA
Livleen Veslemes is the former CEO of bioLytical Laboratories. With 20 years’ experience, Livleen brings expertise from diverse industries including medical devices, biotechnology, consumer packaged goods, telecommunications, and hospitality. She has had senior roles in both privately held and publicly traded companies at every stage of the lifecycle from start-up through to global commercialization.
Under Livleen’s leadership, bioLytical Laboratories was ranked on Business in Vancouver’s Top 100 Fastest Growing Companies list three years in a row, is the winner of the 2018 Lifesciences BC’s Growth Stage MedTech Company of the Year, honoured as the 2019 BC Exporter of the Year by the Canadian Manufacturers & Exporters Association, and listed in the Globe and Mail’s Report on Business as one of the Top 400 Growing Companies in Canada.
Trevor Skutezky, MD, FRCPC, MBA, BASc
Trevor is a physician specializing in Emergency Medicine at Vancouver General Hospital. He holds an undergraduate degree in engineering from Queen's University and a Master of Business Administration from Ivey Business School. He brings experience in project management, quality improvement, medical research and first hand healthcare knowledge to the Difinity team.
Aidan McParland, MD, MSc
Aidan is a resident physician specializing in Emergency Medicine at Vancouver General Hospital. He holds a master's degrees in Pain Biology at the University of New England and completed his medical degree at the University of Toronto. He brings experience in basic science, clinical trials, as well as academic and organizational leadership to the Difinity team
Roh Amromanoh, BME, MEng
Roh holds a Biosystems Engineering undergraduate degree specializing in Biomedical Engineering, as well as a Master of Science in Mechanical Engineering from the University of Manitoba. He is currently a Master of Business Administration (MBA) student at the University of Manitoba and is passionate about start-ups and medical device innovation and management. He brings a combination of technical and business knowledge to the Difinity team.
Nicholas Monfries, MD
Nicholas is an emergency medicine resident physician at the University of British Columbia and is currently completing his subspecialty training in Pediatric Emergency Medicine at the University of Calgary. He is passionate about health system innovation and medical leadership, and has served as a leader and representative on several provincial and national medical organizations.
Since starting NeedSafe, we have submitted patents for IP protection and developed a working prototype.
We have submitted patents in various jurisdictions and have developed an alpha prototype with early functionality.
We have submitted grant proposals for research and development.
We are aiming to have a fully functioning device to undergo testing and manufacturing by the end of Q2 2021. We hope to submit and meet FDA and Health Canada Regulations for our device by the end of Q4 2022.
Our goal is to obtain seed funding to further develop, test, and manufacture our device with the goal of undergoing verification/validation testing for FDA and Health Canada approval.
We are aiming to have NeedSense being tested for data collection and processing in hospitals by the end of Q2 2022.
Let's Get In Touch
We look forward to hearing from you.